Internal Medicine, Medical Oncology · Edison, NJ
NPI
1295962728
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
34-36 Progress St Ste B2
Edison, NJ, 08820
Phone (908) 757-9696
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
78,190 services
Medicare patients, 2024
651
Average age 76
Drug cost, 2024
$3.7M
1,360 prescriptions
Company payments, 2025
$128
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seeta Trivedi was code J1439 (injection, ferric carboxymaltose, 1 mg), 28,500 times for 31 patients. In total Seeta Trivedi billed 78,190 services in 122 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 28,500 | 31 | $0.87 | $25K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,600 | 11 | $44.58 | $294K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 4,020 | 12 | $2.31 | $9,276 |
| J1756 Injection, iron sucrose, 1 mg | Office | 3,800 | 11 | $0.17 | $641 |
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 16 | $20.41 | $64K |
| 99232 Hospital E&M - Subsequent | Facility | 892 | 229 | $71.87 | $64K |
| 36415 Venipuncture Blood Collection | Office | 556 | 244 | $8.64 | $4,801 |
| 85025 Blood Count | Office | 515 | 226 | $7.60 | $3,912 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 380 | 17 | $0.09 | $33.88 |
| 99214 Office E&M - Established | Office | 365 | 167 | $110.79 | $40K |
| 96372 Injection Administration | Office | 284 | 86 | $12.73 | $3,616 |
| 85027 Blood Count | Office | 255 | 115 | $6.30 | $1,607 |
| 99213 Office E&M - Established | Office | 251 | 173 | $75.83 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 66 | $14.34 | $1,720 |
| 96413 Chemotherapy Administration | Office | 116 | 49 | $124.39 | $14K |
By year: 2022 $1.4M for 93,635 services; 2023 $1.6M for 97,307 services; 2024 $1.2M for 78,190 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 556 | 244 | $8.64 | $4,801 |
| 85025 Blood Count | 515 | 226 | $7.60 | $3,912 |
| 85027 Blood Count | 255 | 115 | $6.30 | $1,607 |
Medicare prescription drug claims, 2024
In 2024, the drug Seeta Trivedi prescribed most often to Medicare patients was Anastrozole, with 167 prescriptions and refills. In total Seeta Trivedi wrote 1,360 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 167 | 491 | 49 | $4,146 |
| Eliquis Apixaban | 145 | 179 | 23 | $102K |
| Procrit Epoetin Alfa | 88 | 88 | 12 | $108K |
| Aranesp Darbepoetin Alfa In Polysorbat | 55 | 55 | 13 | $113K |
| Letrozole Generic | 46 | 128 | 14 | $1,306 |
| Acyclovir Generic | 43 | 73 | Under 11 | $312 |
| Tamoxifen Citrate Generic | 40 | 68 | Under 11 | $955 |
| Hydroxyurea Generic | 38 | 93 | Under 11 | $1,456 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 31 | 31 | 17 | $937 |
| Revlimid Lenalidomide | 30 | 30 | Under 11 | $452K |
| Xarelto Rivaroxaban | 27 | 66 | Under 11 | $35K |
| Imbruvica Ibrutinib | 27 | 27 | Under 11 | $414K |
| Neulasta Pegfilgrastim | 26 | 26 | Under 11 | $186K |
| Gabapentin Generic | 23 | 31 | Under 11 | $135 |
| Azacitidine Generic | 22 | 23 | Under 11 | $34K |
Brand drugs: 643 claims; generic drugs: 717 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seeta Trivedi $128 ($128 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $37.02.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.